About: Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 January 1989

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в січні 1989 (uk) article scientifique publié en 1989 (fr) im Januar 1989 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en xineru de 1989 (ast) artikull shkencor i botuar më 01 janar 1989 (sq) scientific article published on 01 January 1989 (en)
publication date	wds:Q69936133-10070C03-D387-489C-A011-6A230C03AF1E
publication date	1989-01-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q69936133-17617397-B330-4BF3-AA85-A3B126115DE9
language of work or name	English
author name string	wds:Q69936133-060F292D-3E3B-4502-8756-81744F6990BE wds:Q69936133-358981EE-5684-4802-A2F3-720921BE1D3F wds:Q69936133-78D4BA5C-B97B-4126-9310-6C3D4CCD8678 wds:Q69936133-8BAFFDA1-7015-44DF-A51E-5AEECA977EFE wds:Q69936133-9A8770FE-C115-4195-A103-5E1F44B89535 wds:Q69936133-9BF336BF-560E-44BC-9589-1EB252442984 wds:Q69936133-A2643F6F-D6FD-4EE7-BC6F-263717B9D038 wds:Q69936133-F0520017-5BD4-472B-88F4-9FD42540D2C4
author name string	A L Taylor J McNatt J T Willerson L M Buja P Golino W B Campbell M Rosolowsky J H Ashton
rdfs:label	Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (en) Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (nl) Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (sq)
skos:prefLabel	Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (en) Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (nl) Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (sq)
name	Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (en) Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (nl) Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (sq)
title	wds:Q69936133-7B692112-4A23-46A7-BC15-78E3D5821E30
title	Local platelet activation causes vasoconstriction of large epicardial canine coronary arteries in vivo. Thromboxane A2 and serotonin are possible mediators (en)
page(s)	wds:Q69936133-4F86A002-5D92-45C5-8FA4-A2E9DB507952
page(s)	154-166
instance of	wds:Q69936133-7B1D2DED-715E-4D99-864A-50E321FA36D0
instance of	scholarly article
PubMed ID	wds:Q69936133-EAA41390-9391-47A3-865B-AB4296831AA0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2910540
PubMed ID	2910540
published in	wds:Q69936133-983A4829-7A75-4FF0-896D-88B3018F7244
published in	Circulation
issue	wds:Q69936133-0DEF992A-CD37-4791-BC88-92E4DE0FC17D
volume	wds:Q69936133-EE988BA9-2ADA-4908-954C-92C8C4B58949
issue	1
volume	79
DOI	wds:Q69936133-8D6749CB-74DB-420D-ACD4-68DCA3DE260B
DOI	http://dx.doi.org/10.1161/01.CIR.79.1.154
DOI	10.1161/01.CIR.79.1.154
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q69936133
is cites work of	Intracoronary verapamil for the treatment of distal microvascular coronary artery spasm following ptca Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden A potent 5-hydroxytryptamine receptor (5-HT2A) antagonist, DV-7028, delays arterial thrombosis development in rats. Pathophysiology of unstable angina Management of intracoronary thrombosis complicating percutaneous transluminal coronary angioplasty Effects of U46619 on contractions to 5-HT, sumatriptan and methysergide in canine coronary artery and saphenous vein in vitro Comparison of contractile responses to 5-hydroxytryptamine and sumatriptan in human isolated coronary artery: synergy with the thromboxane A2-receptor agonist, U46619 Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury Dynamics in Thrombus Formation Conversion from chronic to acute coronary heart disease syndromes. Role of platelets and platelet products. Gene therapy to restore prostacyclin presence to injured endothelium Treadmill exercise promotes cyclic alterations in coronary blood flow in dogs with coronary artery stenoses and endothelial injury Reduced platelet serotonin content and release in familial hypercholesterolaemia Serotonin antagonism improves platelet inhibition in clopidogrel low-responders after coronary stent placement: an in vitro pilot study Antiplatelet effect of Z-335, a new orally active and long-lasting thromboxane receptor antagonist Lack of effect of glycoprotein IIb/IIIa blockade on myocardial platelet or polymorphonuclear leukocyte accumulation and on infarct size after transient coronary occlusion in pigs Effects of acute hormone therapy on recurrent ischemia in postmenopausal women with unstable angina Relationship of admission hematological indexes with myocardial reperfusion abnormalities in acute ST segment elevation myocardial infarction patients treated with primary percutaneous coronary interventions Partially Defective Store Operated Calcium Entry and Hem(ITAM) Signaling in Platelets of Serotonin Transporter Deficient Mice Regulation of Coronary Blood Flow. Effects of gallopamil on epinephrine and norepinephrine plasmatic levels and on TxB2 and beta-tg release in patients with coronary artery disease during adrenergic stimulus with cold pressor test Effects of cigarette smoking or ingestion of nicotine on platelet 5-hydroxytryptamine (5-HT) levels in smokers and non-smokers Effect of serotonin and thromboxane A2 on blood flow through moderately well developed coronary collateral vessels The triphasic pattern of skeletal muscle blood flow in reperfusion injury: an experimental model with implications for surgery on the acutely ischaemic lower limb Cardiovascular therapies in the 1990s. An overview Intimal injury in a transiently occluded coronary artery increases myocardial necrosis. Effect of aspirin Secretome of apoptotic peripheral blood cells (APOSEC) attenuates microvascular obstruction in a porcine closed chest reperfused acute myocardial infarction model: role of platelet aggregation and vasodilation Platelet activation during myocardial ischaemia: a contributory arrhythmogenic mechanism Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study. The Open Artery Hypothesis: Past, Present, and Future Mechanism of actions of sumatriptan on coronary flow before and after endothelial dysfunction in guinea-pig isolated heart Impaired NO release from bovine aortic endothelial cells exposed to activated platelets Antithrombotic and thrombolytic therapy in patients undergoing coronary artery interventions: a review. Correlation between clinical and morphologic findings in unstable angina Salutary effects of aspirin in coronary artery disease are not limited to its platelet inhibitory effects Should all patients with risk factors for ischemic heart disease receive aspirin? James Thornton Willerson, MD: a conversation with the editor. Interview by William Clifford Roberts. Effects of trimetazidine on in vivo coronary arterial platelet thrombosis Instability of reference diameter in the evaluation of stenosis after coronary angioplasty: percent diameter stenosis overestimates dilative effects due to reference diameter reduction. A new thromboxane receptor antagonist, Z-335, ameliorates experimental thrombosis without prolonging the rat tail bleeding time Potential of combined thromboxane A2 and serotonin antagonists to prevent the development of unstable angina and acute myocardial infarction. Effects of serotonin and thromboxane A2 on the coronary collateral circulation Documentation of experimentally induced thrombus formation using intravascular ultrasound Mechanisms of electrical vasoconstriction.

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 194 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software